中国动脉化冠状动脉旁路移植术专家共识2019版

2019-04-30 中国医师协会心血管外科医师分会 中华心胸外科杂志.2019-34(4):193-200.

为了进一步改善CABG的远期疗效,由中国医师协会心血管外科医师分会冠心病学组发起,组织了全国该领域的知名专家,参考欧美最新研究和指南,并结合我国国情,以循证医学为准绳制定了本共识,以期提倡和推动我国动脉化CABG的普及,并鼓励参与国际合作和自主开展临床研究的探索。

中文标题:

中国动脉化冠状动脉旁路移植术专家共识2019版

发布日期:

2019-04-30

简要介绍:

为了进一步改善CABG的远期疗效,由中国医师协会心血管外科医师分会冠心病学组发起,组织了全国该领域的知名专家,参考欧美最新研究和指南,并结合我国国情,以循证医学为准绳制定了本共识,以期提倡和推动我国动脉化CABG的普及,并鼓励参与国际合作和自主开展临床研究的探索。 

拓展指南:冠状动脉相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=中国动脉化冠状动脉旁路移植术专家共识2019版)] GetToolGuiderByIdResponse(projectId=1, id=30aa01c001e623d8, title=中国动脉化冠状动脉旁路移植术专家共识2019版, enTitle=, guiderFrom=中华心胸外科杂志.2019-34(4):193-200., authorId=null, author=, summary=为了进一步改善CABG的远期疗效,由中国医师协会心血管外科医师分会冠心病学组发起,组织了全国该领域的知名专家,参考欧美最新研究和指南,并结合我国国情,以循证医学为准绳制定了本共识,以期提倡和推动我国动脉化CABG的普及,并鼓励参与国际合作和自主开展临床研究的探索。 , cover=, journalId=null, articlesId=null, associationId=319, associationName=中国医师协会心血管外科医师分会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Apr 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>为了进一步改善CABG的远期疗效,由中国医师协会心血管外科医师分会冠心病学组发起,组织了全国该领域的知名专家,参考欧美最新研究和指南,并结合我国国情,以循证医学为准绳制定了本共识,以期提倡和推动我国动脉化CABG的普及,并鼓励参与国际合作和自主开展临床研究的探索。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>冠状动脉</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=724821c001e5a714" title="对2018年SCCT关于女性冠状动脉CT血管成像专家共识的解读" target=_blank>对2018年SCCT关于女性冠状动脉CT血管成像专家共识的解读</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=b554e1c001e506c0" title="冠状动脉支架脱载的处理和预防专家共识" target=_blank>冠状动脉支架脱载的处理和预防专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=426951c001ea55a5" title="急性冠状动脉综合征患者早期抗栓治疗及院间转运专家共识" target=_blank>急性冠状动脉综合征患者早期抗栓治疗及院间转运专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=0e8c21c001e295ce" title="中国冠状动脉血流储备分数测定技术临床路径专家共识" target=_blank>中国冠状动脉血流储备分数测定技术临床路径专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=2565f1c001e25002" title="2019 AHA科学声明:无阻塞性冠状动脉疾病心肌梗死患者的诊断和管理" target=_blank>2019 AHA科学声明:无阻塞性冠状动脉疾病心肌梗死患者的诊断和管理</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E5%86%A0%E7%8A%B6%E5%8A%A8%E8%84%89" target=_blank>有关冠状动脉更多指南</a></ul>, tagList=[TagDto(tagId=2769, tagName=冠状动脉旁路移植术)], categoryList=[CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=30363, appHits=307, showAppHits=24, pcHits=21060, showPcHits=10400, likes=95, shares=28, comments=4, approvalStatus=1, publishedTime=Thu Jul 18 00:54:43 CST 2019, publishedTimeString=2019-04-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Jul 18 00:54:43 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:35:08 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中国动脉化冠状动脉旁路移植术专家共识2019版)])
中国动脉化冠状动脉旁路移植术专家共识2019版
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1206928, encodeId=1aa1120692895, content=学习中感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210201/f9ebd76673be43709bf11ecf3e05d29a/4ceebf8544374796ac74a7ce757d6c8f.jpg, createdBy=28e01512509, createdName=40386, createdTime=Tue Mar 29 15:52:26 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205895, encodeId=02f91205895d7, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210201/f9ebd76673be43709bf11ecf3e05d29a/4ceebf8544374796ac74a7ce757d6c8f.jpg, createdBy=28e01512509, createdName=40386, createdTime=Fri Mar 25 17:11:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069634, encodeId=ec341069634f6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Fri Nov 12 13:56:30 CST 2021, time=2021-11-12, status=1, ipAttribution=)]
    2022-03-29 40386

    学习中感谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1206928, encodeId=1aa1120692895, content=学习中感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210201/f9ebd76673be43709bf11ecf3e05d29a/4ceebf8544374796ac74a7ce757d6c8f.jpg, createdBy=28e01512509, createdName=40386, createdTime=Tue Mar 29 15:52:26 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205895, encodeId=02f91205895d7, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210201/f9ebd76673be43709bf11ecf3e05d29a/4ceebf8544374796ac74a7ce757d6c8f.jpg, createdBy=28e01512509, createdName=40386, createdTime=Fri Mar 25 17:11:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069634, encodeId=ec341069634f6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Fri Nov 12 13:56:30 CST 2021, time=2021-11-12, status=1, ipAttribution=)]
    2022-03-25 40386

    学习中

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1206928, encodeId=1aa1120692895, content=学习中感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210201/f9ebd76673be43709bf11ecf3e05d29a/4ceebf8544374796ac74a7ce757d6c8f.jpg, createdBy=28e01512509, createdName=40386, createdTime=Tue Mar 29 15:52:26 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205895, encodeId=02f91205895d7, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210201/f9ebd76673be43709bf11ecf3e05d29a/4ceebf8544374796ac74a7ce757d6c8f.jpg, createdBy=28e01512509, createdName=40386, createdTime=Fri Mar 25 17:11:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069634, encodeId=ec341069634f6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Fri Nov 12 13:56:30 CST 2021, time=2021-11-12, status=1, ipAttribution=)]
    2021-11-12 Doctoryangbai

    学习了

    0